choose between Byetta (exenatide) and Victoza (liraglutide) for type 2 diabetes
May 2011
Canadians will now be able to choose between Byetta (exenatide) and Victoza (liraglutide) for type 2 diabetes.
Byetta is the new competitor to Victoza. They're both GLP-1 receptor agonists and given by SC injection.
GLP-1 (glucagon-like peptide-1) is an incretin hormone that's secreted by the gut...mainly after meals. GLP-1 stimulates the pancreas to INCREASE insulin and DECREASE glucagon secretion.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive